*** Fundraising: We
wish to take this time to thank those that donated to reduce our deficit
and to wish them the very best Christmas season ever. Our deficit is currently down to $130,
and with 7 days remaining til the first of the month and New Year. We would like to thank those that have
contributed so far and to acknowledge what a sacrifice we know it was on such a
holiday season.
If
you have benefited in anyway from our blog and our work, we
hope you will contribute, so we can stay on the net, by clicking on the pay pal button off
to the right of the blog. Bless
you all for your support over these almost 4 years. No matter how
it turns out, I truly believe we have all made a difference. Bless
you all, this Christmas and New Years season.
Vatic Note: Well, well, its about time this blew up. We have published blogs on here that proved many deaths from side affects could have been prevented had the FDA not had a revolving door with the drug industry. This, is, hopefully, only the first of many.
The entire industry needs a good housecleaning and the owners/shareholders should be held accountable both criminally and civially for what they have done or allowed to be done in harming their patients. Shame on them for violating their fiduciary responsiblity to those they were suppose to serve AT A PROFIT.
GlaxoSmithKline Forced To Stop Paying Doctors To Promote Drugs After Major Bribery Investigation
http://www.davidicke.com/headlines/glaxosmithkline-forced-to-stop-paying-doctors-to-promote-drugs-after-major-bribery-investigation/
by David Icke, December 21st, 2013
Marco Torres, Prevent Disease
Waking Times
GlaxoSmithKline (GSK) said this week it will respond to pressure to
stop paying doctors to promote its products through speaking engagements
and end linking compensation for its sales representatives to the
number of prescriptions doctors write.
The move comes amid a major
bribery investigation in China. It also plans to stop payments to healthcare professionals for attendance at medical conferences by the start of 2016.
Authorities say a major bribery investigation in China accused
Britain’s largest drugmaker of corrupt payments to doctors and officials
to boost its drug sales.
In 2012, GSK was fined $3 billion and plead guilty to federal charges to
resolve a slew of criminal and civil issues stemming from its use of
kickbacks, misbranding and other misconduct to market drugs such as
Paxil, Wellbutrin and Advair.
The agreement was the largest health care fraud settlement in
history, spanning nearly every state, according to the Justice
Department. It’s was also the largest payment ever by a drug company.
The company illegally marketed depression drug Paxil to children and
teens, even sponsoring dinners and spa programs in the drug’s name,
prosecutors said.
Glaxo also used sham advisory boards and speakers at lavish resorts
to promote depression drug Wellbutrin as an option for weight loss and a
remedy for sexual dysfunction and substance addiction, according to the
government. Customers were urged to use higher-than-approved dosages,
the government said.
Medical Journals Corrupt
GSK as well as the largest pharmaceutical companies have been paying off the researchers of medical studies for decades.
Richard Smith, the ex-editor of the British Medical Journal (BMJ),
publicly criticized his former publication, saying the BMJ was too
dependent on advertising revenue to be considered impartial.
Smith
estimates that between two-thirds to three-quarters of the trials
published in major journals — Annals of Internal Medicine, Journal of
the American Medical Association, Lancet and New England Journal of
Medicine — are funded by the industry, while about one-third of the
trials published in the BMJ are thus funded.
He further adds that trials are so valuable to drug companies that
they will often spend upwards of $1 million in reprint costs (which are
additional sources of major revenues for medical journals).
Consumers
trust medical journals to be the impartial and “true” source of
information concerning a prescription drug, but few are privy to what is
truly going on behind the scenes at both drug trials and medical
journals.
Scientists
who conduct drug trials may be hard-pressed to stay impartial when the
manufacturers so often pay them for lectures and consultations, or when
they are conducting research that has been funded by the company.
In
addition, as stated by doctors Mark Hyman and Mark Liponis in
Ultraprevention, since drug companies are so reliant on the word of
doctors, they often visit doctors’ offices to hand out free samples,
take the staff out to lunch, offer free gifts — including toys for kids,
seminars at expensive restaurants and junkets to the Caribbean islands —
and frequently sponsor continuing education for doctors.
Bribery Coming To An End
GSK is not the only culprit. Pfizer, Novartis, Merck, Eli Lilly and
Sanofi have all been heavily criticized and accused of initiating
scandals in medical research.
“It’s all coming to an end,” says Dr. Robin Herring. “There is no
longer a place for corrupting the health of this country and drug
companies are finally being exposed for this shady practice,” she
stated.
Opponents of the perceived corruption are beginning to offer many
solutions. A change may be in the cards, and as Richard Gerber, MD,
notes, the number of patients seeking alternative medical answers to
their problems is becoming too large for mainstream medical media to
ignore.
Gerber says that some medical journals are even publishing
articles that explore the nature of these “unorthodox” treatments and
discuss why patients are seeking alternative health care.
GSK’s admission will surely not be the last for those at the top of big pharma’s food chain.
The article is reproduced in accordance with Section 107 of title 17 of the Copyright Law of the United States relating to fair-use and is for the purposes of criticism, comment, news reporting, teaching, scholarship, and research.
No comments:
Post a Comment